Introduction
============

Public reporting of hospital readmissions for heart failure (HF) underscores its importance as a measure of quality of care and as a metric for Medicare reimbursements.^[@b1]^ Among different racial/ethnic groups, older black and Hispanic patients have been reported to have higher 30‐day readmission rates compared with whites, in part related to the hospitals where care was provided.^[@b2]--[@b3]^ Although these data indicate racial/ethnic disparities in HF readmissions, lack of longer follow‐up data has limited the evaluation of how short‐term rehospitalizations may impact long‐term outcomes. A statewide study documented that minorities were more likely to be rehospitalized and were paradoxically less likely to die within 1 year, yet it remains unknown if these results are similar across the United States.^[@b4]^ A postulated explanation for these observations is that HF hospitalization in minority populations may not necessarily imply more severe disease but rather may result from poorer access to follow‐up care and/or poorer understanding of outpatient management of their symptoms and medications.

Understanding racial/ethnic differences in HF rehospitalizations and mortality may be crucial in helping to guide initiatives aimed at promoting health equity, reducing the financial burden of readmissions, and improving outcomes. We sought to evaluate the hypothesis that in contrast to white patients, black, Hispanic, and Asian patients have more comorbid diseases and higher rates of short‐ and long‐term readmissions but better short‐ and long‐term survival.^[@b5]--[@b7]^ Our 2 main objectives were to (1) compare 30‐day readmission and 1‐year mortality rates for HF among these 4 race/ethnic groups and (2) examine the impact of clinical profile and socioeconomic status (SES) variables on HF outcomes stratified by race/ethnicity.

Methods
=======

Data Sources
------------

Data for this analysis were derived from the Get With The Guidelines (GWTG)‐HF registry linked with Medicare inpatient data. The GWTG‐HF registry is an ongoing national, voluntary program formed to improve quality of care for patients hospitalized with HF. Its design and data variables have been previously reported.^[@b8]--[@b9]^ Data elements, including patient characteristics, medical history, medications, laboratory data, contraindications to treatment, inpatient care, outcomes, and hospital characteristics, were entered into an online interactive case report form and patient management tool (Outcome Sciences, Inc, a Quintiles Company). Using standardized definitions, trained personnel abstracted the data. Race/ethnicity data were recorded by patient self‐reporting by admissions or medical staff during registration. Race was recorded as part of a multiple‐choice data entry tool (ie, white, black, Asian, American Indian/Alaska native, and Native Hawaiian/Pacific Islander). A separate data element for Hispanic ethnicity (ie, yes versus no/not documented) was also implemented. All participating institutions were required to comply with local regulatory and privacy guidelines and, if required, to secure institutional review board approval. Because data were used primarily at the local site for quality improvement, sites were granted a waiver of informed consent under the common rule. Through an Internet‐based system, data quality was monitored for completeness and accuracy. Outcome Sciences, Inc served as the data collection and coordinating center for GWTG. The Duke Clinical Research Institute served as the data analysis center and examined the aggregate deidentified data for research purposes.

The Medicare data included Part A (inpatient) claims and the associated denominator file. Medicare inpatient claims data from January 1, 2005, through December 31, 2011, were linked with data from the GWTG‐HF registry, matching by admission and discharge dates, hospital, date of birth, and sex.^[@b10]^

Study Population
----------------

The study population for this analysis was based on those patients who (1) came from hospitals in GWTG‐HF registry that were fully participating, (2) had a principal HF diagnosis, (3) were ≥65 years old with a GWTG‐HF registry hospitalization linked to Medicare, (4) were discharged between January 1, 2005, and December 31, 2011, (5) were enrolled in fee‐for‐service Medicare at discharge, and (6) whose race/ethnicity were recorded as white (non‐Hispanic white), black (non‐Hispanic black), Hispanic, or Asian (non‐Hispanic Asian/Pacific Islander). If multiple hospitalizations exist for a patient, the first hospitalization was selected as the index hospitalization for this study.

Outcome Measures
----------------

For outcomes (ie, length of hospital stay and mortality) assessed post index admission, all patients after the aforementioned exclusions were analyzed. For outcomes (ie, readmission, hospital stay, mortality, and composite of mortality/readmission) post index discharge, the analysis was further limited to those who were discharged alive but did not leave against medical advice and were not discharged/transferred to either another short‐term hospital or hospice or had discharge destination missing.

The primary outcome measures were 30‐day and 1‐year rehospitalization, length of hospital stay, and mortality. More specifically, we examined all‐cause readmission post index discharge (30‐day and 1‐year), cardiovascular readmission post index discharge (30‐day and 1‐year), all‐cause mortality post index admission (30‐day and 1‐year), all‐cause mortality post index discharge (30‐day and 1‐year), and composite of mortality and all‐cause readmission post index discharge (30‐day and 1‐year). In addition, we assessed days in hospital for index admission and hospital stay within 30 days or 1 year post index discharge. Readmissions excluded the index hospitalization claim, transfers to or from another hospital, and admissions for rehabilitation.

Statistical Analysis
--------------------

There are 2 study subpopulations: 1 for mortality and hospital stay post index admission and the other for mortality, readmission, composite of mortality/readmission, and total hospital days post index discharge.

Baseline characteristics of study population were described by race/ethnic groups, by using proportions for categorical variables and means with SD values for normally distributed continuous variables and medians with 25th and 75th percentiles for continuous variables with skewed distribution. Differences between the 4 race groups were tested by using χ^2^ tests for categorical variables and Wilcoxon tests for continuous variables. Characteristics of the study population were based on GWTG‐HF Registry data and included demographics (age, sex), clinical characteristics, including medical history, vital signs at admission (systolic blood pressure, heart rate, respiratory rate), lab work at admission (blood urea nitrogen, creatinine, hemoglobin, and sodium), ejection fraction, medications at discharge (angiotensin‐converting enzyme inhibitor, angiotensin II receptor blocker, β‐blocker, digoxin, diuretic, aldosterone antagonist, aspirin, and anticoagulants), length of stay \>7 days for the index hospitalization, and year of index hospitalization, and hospital characteristics, namely geographic region, number of beds, teaching status, and rural location. Most variables had \<5% missing except brain natriuretic peptide and missing on continuous variables were imputed to median and missing on categorical variables were imputed to dominant level.

Additionally, observed event rates were described for each race/ethnic group. For mortality, incidence at 30 days and 1 year were calculated by using Kaplan--Meier estimates. The mortality and composite of mortality/readmission were compared between race groups by using log‐rank tests. For readmissions, incidence at 30 days and 1 year were calculated by using estimates from the cumulative incidence function to account for the competing risk of mortality. The readmission outcomes were compared by using Gray tests. The hospital stay days were reported as a continuous variable and compared between the 4 race groups by using Wilcoxon tests.

Finally, the association of race/ethnicity with each outcome was assessed by using adjusted regression modeling for patient and hospital characteristics. For time‐to‐event outcomes, the adjusted association of race/ethnicity with outcome was assessed by using multivariable Cox proportional hazards models, where robust standard errors were used to account for the clustering of patients by hospital. The variables described here, except ejection fraction and discharge medications, were included in addition to the main variable of interest race groups with white as the referent. The adjustment was performed in 3 steps: adjustment for patient characteristics only, adjustment for patient and hospital characteristics together, followed by additional adjustment for SES data. SES variables included mean household income estimate, percentage of persons aged ≥25 years with ≥4 years of college (2006--2010 Census), and percentage of persons aged ≥25 years with high school diploma or greater (2006--2010 Census). Negative binomial regression model with individual specific offset was performed to examine the association of race/ethnicity and total days rehospitalized. GEE approach was used to account for within hospital clustering. In the model, the individual specific offset was determined by logarithm of length of follow‐up until censoring and the hospital stay days outcome was capped by the number of follow‐up days. Therefore, the individual specific offset allows model to account for the fact that patients had different length of follow‐up days. Other covariates in the model are same as those we used in the analyses of mortality and readmission outcomes. Race/ethnic group and geographic region interactions were also explored.

All tests were evaluated at a 2‐sided significance level of *P*\<0.05. All statistical analyses were performed by using SAS 9.2 (SAS Institute).

Results
=======

Patient and Hospital Characteristics
------------------------------------

The linked GWTG‐HF and Medicare data included 175 693 patients. After further excluding 358 hospitals with limited participation and data capture (n=110 656 patients); 68 hospitals with \<25 patients in the cohort (n=844 patients); patients with no fee‐for‐service eligibility at index discharge (n=2473); patients with race missing (n=1768), unable to determine (n=1332), or American Indian/Alaska native (n=210); patients without ≥1 documented admission vital signs (eg, systolic blood pressure, heart rate, or respiratory rate) (n=3979); and patients without at least 1 documented admission laboratory data result (eg, serum creatinine, blood urea nitrogen, or sodium) (n=7282), the final study population was composed of 47 149 patients from 213 hospitals across the United States. The composition by race/ethnicity was as follows: white (83.2%; n=39 213), black (10.5%; n=4946), Hispanic (5.0%; n=2347), and Asian/Pacific Islander patients (1.4%; n=643). From the study population of 47 149 patients, we excluded those who left against medical advice (n=135), were transferred out (n=685), were discharged to hospice (n=1220), died during the index admission (n=1413), and had ndocumented or undetermined discharge destination (n=551), and the analysis sample for the outcomes of interest post index discharge included 43 145 patients.

Baseline patient characteristics are summarized in [Table 1](#tbl01){ref-type="table"}. More than half (54.5%) of the population were women. Overall, white patients were older and had the highest proportion of octogenarians. Asian patients had the highest household income and were most likely to have a college degree; Hispanic patients were least likely to have a high school diploma. Compared with other racial/ethnic groups, white patients were more likely to have a history of atrial fibrillation, chronic obstructive pulmonary disease, ischemic etiology of HF, and peripheral vascular disease, whereas non‐Hispanic black patients were more likely to have anemia, hypertension, renal insufficiency, smoking, and a history of stroke. Hispanic patients were more likely to have diabetes, while Asian patients had a stronger history of valvular heart disease. On admission, black and Asian patients were more likely to have higher brain natriuretic peptide levels; black and Hispanic patients were more likely to have lower left ventricular systolic ejection fraction. At discharge, β‐blockers and angiotensin‐converting enzyme inhibitors were more likely to be prescribed to black patients, while angiotensin II receptor blockers and aldosterone antagonists were more likely to be prescribed to Asian and white patients, respectively. Black patients were more likely to be treated at higher‐volume, teaching hospitals. Geographically, more black and Hispanic patients were discharged from hospitals in the south, whereas more Asian patients were treated at centers in the western region.

###### 

Baseline Characteristics

  Variable                                                                      Non‐Hispanic White (n=39 213)   Non‐Hispanic Black (n=4946)   Hispanic (n=2347)           Non‐Hispanic Asian/Pacific Islander (n=643)   *P* Value[\*](#tf1-1){ref-type="table-fn"}
  -------------------------------------------------------------- -------------- ------------------------------- ----------------------------- --------------------------- --------------------------------------------- --------------------------------------------
  Demographics                                                                                                                                                                                                          
  Age, y                                                         Median (IQR)   81 (75 to 87)                   76 (70 to 83)                 78 (71 to 84)               80 (74 to 86)                                 \<0.001
  Age (grouped), %                                               ≥80            7.1                             5.5                           2.1                         54.9                                          \<0.001
  75 to 79                                                       18.1           20.1                            20.1                          19.1                                                                      
  70 to 74                                                       13.9           20.7                            19.0                          16.0                                                                      
  65 to 69                                                       11.0           23.7                            18.9                          10.0                                                                      
  Female, %                                                                     53.9                            59.9                          53.1                        55.2                                          \<0.001
  Social economic status                                                                                                                                                                                                
  Median household income estimate, US\$                         Median (IQR)   45 798 (40 780 to 53 577)       45 359 (41 087 to 53 363)     46 566 (38 740 to 53 547)   53 494 (49 284 to 66 476)                     \<0.001
  Persons aged ≥25 years with high school diploma, %             Median (IQR)   86.2 (83.1 to 89.0)             84.3 (81.4 to 87.1)           80.3 (75.5 to 84.9)         85.4 (75.9 to 89.9)                           \<0.001
  Persons aged ≥25 years with ≥4 years of college education, %   Median (IQR)   25.2 (17.8 to 29.2)             27.9 (21.3 to 33.2)           26.7 (16.9 to 30.7)         29.0 (27.7 to 33.2)                           \<0.001
  Medical history, %                                                                                                                                                                                                    
  Anemia                                                                        19.6                            21.8                          16.4                        16.2                                          \<0.001
  Atrial fibrillation/flutter                                                   41.5                            22.8                          22.5                        31.4                                          \<0.001
  COPD or asthma                                                                29.5                            28.8                          25.5                        21.2                                          \<0.001
  Depression                                                                    10.9                            5.3                           6.7                         5.4                                           \<0.001
  Diabetes                                                                      37.6                            49.0                          54.6                        43.2                                          \<0.001
  Heart failure                                                                 52.5                            55.3                          54.5                        46.7                                          \<0.001
  Hypertension                                                                  74.9                            85.6                          84.8                        81.2                                          \<0.001
  ICD or CRT‐D                                                                  9.2                             9.4                           8.7                         6.8                                           0.155
  Ischemic cause: Med Hx of CAD, MI, prior PCI or CABG                          60.0                            46.1                          57.9                        54.4                                          \<0.001
  Peripheral arterial disease                                                   14.6                            12.1                          11.8                        7.9                                           \<0.001
  Renal insufficiency                                                           18.7                            25.8                          19.4                        22.6                                          \<0.001
  Smoking                                                                       8.5                             13.7                          8.5                         5.3                                           \<0.001
  CVA/TIA                                                                       16.5                            18.9                          13.2                        17.7                                          \<0.001
  Valvular heart disease                                                        14.9                            9.4                           9.5                         15.9                                          \<0.001
  Vital signs at admission                                                                                                                                                                                              
  Heart rate, bpm                                                Median (IQR)   80.0 (70.0 to 94.0)             80.0 (71.0 to 95.0)           80.0 (70.0 to 95.0)         82.0 (70.0 to 98.0)                           \<0.001
  Systolic blood pressure, mm Hg                                 Median (IQR)   137.0 (119.0 to 157.0)          146.0 (126.0 to 170.0)        143.0 (123.0 to 165.0)      142.0 (122.0 to 164.0)                        \<0.001
  Lab work at admission                                                                                                                                                                                                 
  Sodium, mEq/L                                                  Median (IQR)   138 (136 to 140)                139 (137 to 141)              138 (135 to 140)            138 (134 to 140)                              \<0.001
  BNP, pg/mL                                                     Median (IQR)   766 (391 to 1485)               832 (329 to 1850)             763 (348 to 1642)           1000 (481 to 2099)                            \<0.001
  Creatinine, mg/dL                                              Median (IQR)   1.3 (1.0 to 1.8)                1.4 (1.1 to 2.1)              1.3 (1.0 to 1.9)            1.3 (1.0 to 2.0)                              \<0.001
  BUN, mg/dL                                                     Median (IQR)   26 (19 to 37)                   26 (17 to 35)                 26 (19 to 37)               27 (19 to 42)                                 \<0.001
  Hemoglobin, g/dL                                               Median (IQR)   11.8 (10.6 to 13.1)             11.8 (10.4 to 12.6)           11.8 (10.6 to 12.8)         11.8 (10.5 to 12.9)                           \<0.001
  Ejection fraction                                                                                                                                                                                                     
  LVEF \<40% (combined quantitative and qualitative), %                         36.5                            41.6                          41.8                        31.6                                          \<0.001
  LVEF value, %                                                  Median (IQR)   45 (30 to 57)                   43 (25 to 57)                 40 (27 to 55)               49.5 (34 to 60)                               \<0.001
  Hospital stay                                                                                                                                                                                                         
  Length of stay (transfer out and in excluded), days            Median (IQR)   4.0 (3 to 7)                    4.0 (3 to 7)                  5.0 (3 to 7)                4.0 (3 to 7)                                  \<0.001
  Medications at discharge, %                                                                                                                                                                                           
  ARB                                                                           12.2                            14.0                          18.5                        20.1                                          \<0.001
  ACE‐I                                                                         42.1                            47.8                          46.1                        32.5                                          \<0.001
  β‐Blocker                                                                     71.0                            74.6                          72.6                        66.6                                          \<0.001
  Aldosterone antagonist                                                        13.4                            12.7                          12.7                        9.6                                           0.012
  Anticoagulants                                                                30.7                            19.4                          19.4                        17.9                                          \<0.001
  Hospital characteristics                                                                                                                                                                                              
  Geographic region, %                                           West           10.7                            3.0                           14.9                        51.3                                          \<0.001
  South                                                          32.1           38.4                            42.6                          20.1                                                                      
  Midwest                                                        29.9           24.8                            8.4                           13.4                                                                      
  Northeast                                                      27.4           33.9                            34.1                          15.2                                                                      
  Teaching hospital, %                                                          58.1                            73.2                          52.1                        51.0                                          \<0.001
  Number of beds                                                 Median (IQR)   400.0 (238 to 593)              438.0 (317 to 610)            346.00 (280 to 483)         400.00 (238 to 501)                           \<0.001
  Rural location, %                                                             8.2                             2.3                           1.5                         1.4                                           \<0.001

ACE‐I indicates angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; BNP, brain natriuretic peptide; BUN, blood urea nitrogen; CABG, coronary artery bypass graft surgery; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; CRT‐D, cardiac resynchronization therapy‐defibrillator; CVA, cerebrovascular accident; ICD, implantable cardiac defibrillator; LVEF, left ventricular ejection fraction; Med Hx, Past Medical History; MI, myocardial infarction; PCI, percutaneous coronary intervention; TIA, transient ischemic attack.

*P* value tests the difference across the 4 race groups.

Unadjusted Outcomes
-------------------

### Thirty‐day outcomes

The unadjusted 30‐day mortality post index admission and all‐cause readmission post index discharge ranged from 5.6% to 9.7% and 22.9% to 26.3%, respectively ([Table 2](#tbl02){ref-type="table"}). In contrast to white patients, black and Hispanic patients had lower short‐term mortality (mortality postdischarge: white 6.3%, black 4.3%, Hispanic 4.4%; *P*\<0.001), higher short‐term all‐cause (non‐Hispanic white 23%, black 25.1%, Hispanic 26.3%; *P*=0.003) and cardiovascular readmissions. Compared with white patients, Asian patients had similar short‐term mortality and all‐cause readmission but slightly higher short‐term cardiovascular readmission.

###### 

Cumulative Incidence of Outcomes Overall and by Race/Ethnicity

  Outcomes                                             Non‐Hispanic White   Non‐Hispanic Black   Hispanic       Non‐Hispanic Asian/Pacific Islander   *P* Value[\*](#tf2-1){ref-type="table-fn"}
  ---------------------------------------------------- -------------------- -------------------- -------------- ------------------------------------- --------------------------------------------
  30‐Day outcomes                                                                                                                                     
  Mortality post index admission, n                    3790 (9.7%)          274 (5.6%)           168 (7.2%)     61 (9.6%)                             \<0.001
  Mortality post index discharge, n                    2227 (6.3%)          199 (4.3%)           94 (4.4%)      35 (6.0%)                             \<0.001
  All‐cause readmission post index discharge, n        8109 (23.0%)         1157 (25.1%)         565 (26.3%)    133 (22.9%)                           0.003
  Cardiovascular readmission post index discharge, n   4146 (11.7%)         612 (13.3%)          304 (14.2%)    80 (13.8%)                            \<0.001
  Mortality/readmission post index discharge, n        9251 (26.2%)         1260 (27.4%)         608 (28.3%)    150 (25.8%)                           0.360
  1‐Year outcomes                                                                                                                                     
  Mortality post index admission, n                    13 940 (37.8%)       1367 (29.5%)         701 (32.2%)    206 (35.1%)                           \<0.001
  Mortality post index discharge, n                    11 323 (34.1%)       1203 (27.7%)         585 (29.2%)    165 (31.2%)                           \<0.001
  All‐cause readmission post index discharge, n        22 390 (66.9%)       3144 (72.9%)         1440 (71.3%)   359 (66.5%)                           \<0.001
  Cardiovascular readmission post index discharge, n   13 642 (41.0%)       2097 (49.0%)         950 (47.5%)    223 (41.5%)                           \<0.001
  Mortality/readmission post index discharge, n        25 068 (74.8%)       3366 (78.0%)         1531 (75.7%)   391 (72.3%)                           0.007

*P* value tests the difference across the 4 race groups.

### One‐year outcomes

The unadjusted 1‐year mortality post index admission ranged from 29.5% to 37.8%, while all‐cause readmission post index discharge ranged from 66.5% to 72.9% ([Table 2](#tbl02){ref-type="table"}). In comparison to white patients, all other groups had lower long‐term mortality (mortality postdischarge: white 34.1%, black 27.7%, Hispanic 29.2%, Asian 31.2%; *P*\<0.001). However, black and Hispanic patients had higher long‐term all‐cause (white 66.9%, black 72.9%, Hispanic 71.3%; *P*\<0.001) and cardiovascular readmission and slightly higher combined mortality and readmission than non‐Hispanic white patients. Asian patients had similar long‐term readmission rates as white patients (Figures [1 through 5](#fig05){ref-type="fig"}).

![One‐year mortality after index heart failure admission stratified by race/ethnicity.](jah3-3-e001134-g1){#fig01}

![One‐year mortality after index hospital discharge stratified by race/ethnicity.](jah3-3-e001134-g2){#fig02}

![One‐year all‐cause readmission stratified by race/ethnicity.](jah3-3-e001134-g3){#fig03}

![One‐year cardiovascular readmission stratified by race/ethnicity.](jah3-3-e001134-g4){#fig04}

![One‐year composite of mortality or all‐cause readmission stratified by race/ethnicity.](jah3-3-e001134-g5){#fig05}

Multivariable Analysis
----------------------

After multivariable adjustment for patient and hospital characteristics, black patients had lower odds of death but showed slightly higher risk of readmission and combined mortality/readmission than did white patients in both short‐ and long‐term follow‐up ([Table 3](#tbl03){ref-type="table"}). Compared with white patients, Hispanic patients had similar 30‐day mortality postadmission, modestly lower 30‐day mortality postdischarge, similar 1‐year mortality, and higher short‐ and long‐term readmission and combined mortality/readmission. In reference to white patients, Asian patients had similar outcomes, except for marginally higher risk of short‐term cardiovascular readmission.

###### 

Associations Between Race/Ethnicity and Outcomes

  Outcome                                           Comparison            Unadjusted            Adjusted for Patient and Hospital Characteristics   Adjusted for Patient, Hospital, and SES Characteristics                                               
  ------------------------------------------------- --------------------- --------------------- --------------------------------------------------- --------------------------------------------------------- --------------------- --------------------- ---------
  30‐Day outcomes                                                                                                                                                                                                                                         
  Mortality post index admission                    Black (vs white)      0.56 (0.49 to 0.64)   \<0.001                                             0.73 (0.64 to 0.83)                                       \<0.001               0.73 (0.65 to 0.83)   \<0.001
  Hispanic (vs white)                               0.73 (0.59 to 0.91)   0.005                 0.88 (0.73 to 1.07)                                 0.192                                                     0.87 (0.71 to 1.06)   0.165                 
  Asian (vs white)                                  0.98 (0.76 to 1.27)   0.897                 0.95 (0.74 to 1.21)                                 0.662                                                     0.99 (0.78 to 1.26)   0.941                 
  Mortality post index discharge                    Black (vs white)      0.67 (0.56 to 0.81)   \<0.001                                             0.88 (0.74 to 1.04)                                       0.123                 0.90 (0.76 to 1.06)   0.209
  Hispanic (vs white)                               0.69 (0.56 to 0.84)   \<0.001               0.81 (0.6 to 0.99)                                  0.034                                                     0.84 (0.67 to 1.05)   0.124                 
  Asian (vs white)                                  0.95 (0.60 to 1.50)   0.830                 0.97 (0.64 to 1.48)                                 0.888                                                     1.03 (0.67 to 1.57)   0.905                 
  All‐cause readmission post index discharge        Black (vs white)      1.10 (1.02 to 1.18)   0.013                                               1.08 (1.00 to 1.17)                                       0.057                 1.05 (0.98 to 1.13)   0.166
  Hispanic (vs white)                               1.15 (1.03 to 1.28)   0.011                 1.16 (1.04 to 1.29)                                 0.008                                                     1.08 (0.98 to 1.19)   0.142                 
  Asian (vs white)                                  1.00 (0.81 to 1.22)   0.975                 1.07 (0.84 to 1.35)                                 0.591                                                     1.03 (0.81 to 1.30)   0.833                 
  Cardiovascular readmission post index discharge   Black (vs white)      1.13 (1.02 to 1.26)   0.021                                               1.12 (1.01 to 1.24)                                       0.029                 1.09 (0.99 to 1.19)   0.083
  Hispanic (vs white)                               1.21 (1.08 to 1.35)   0.001                 1.22 (1.08 to 1.37)                                 0.001                                                     1.11 (0.99 to 1.24)   0.081                 
  Asian (vs white)                                  1.18 (0.96 to 1.45)   0.110                 1.29 (1.00 to 1.68)                                 0.053                                                     1.23 (0.95 to 1.59)   0.112                 
  Mortality/readmission post index discharge        Black (vs white)      1.05 (0.98 to 1.12)   0.172                                               1.07 (1.00 to 1.15)                                       0.059                 1.05 (0.98 to 1.13)   0.130
  Hispanic (vs white)                               1.08 (0.99 to 1.19)   0.085                 1.12 (1.02 to 1.23)                                 0.014                                                     1.06 (0.97 to 1.16)   0.178                 
  Asian (vs white)                                  0.99 (0.81 to 1.20)   0.883                 1.05 (0.85 to 1.30)                                 0.658                                                     1.02 (0.83 to 1.27)   0.826                 
  1‐Year outcomes                                                                                                                                                                                                                                         
  Mortality post index admission                    Black (vs white)      0.72 (0.67 to 0.78)   \<0.001                                             0.88 (0.83 to 0.93)                                       \<0.001               0.88 (0.83 to 0.93)   \<0.001
  Hispanic (vs white)                               0.81 (0.72 to 0.90)   \<0.001               0.94 (0.86 to 1.03)                                 0.199                                                     0.94 (0.86 to 1.02)   0.113                 
  Asian (vs white)                                  0.90 (0.80 to 1.02)   0.109                 0.91 (0.80 to 1.04)                                 0.185                                                     0.92 (0.80 to 1.06)   0.233                 
  Mortality post index discharge                    Black (vs white)      0.77 (0.71 to 0.84)   \<0.001                                             0.93 (0.87 to 0.99)                                       0.030                 0.93 (0.87 to 1.00)   0.040
  Hispanic (vs white)                               0.82 (0.73 to 0.93)   0.001                 0.96 (0.87 to 1.05)                                 0.374                                                     0.96 (0.87 to 1.05)   0.353                 
  Asian (vs white)                                  0.88 (0.76 to 1.02)   0.098                 0.92 (0.79 to 1.07)                                 0.279                                                     0.92 (0.78 to 1.08)   0.308                 
  All‐cause readmission post index discharge        Black (vs white)      1.14 (1.07 to 1.20)   \<0.001                                             1.13 (1.06 to 1.20)                                       0.001                 1.10 (1.04 to 1.16)   \<0.001
  Hispanic (vs white)                               1.10 (1.02 to 1.19)   0.012                 1.13 (1.04 to 1.22)                                 0.002                                                     1.06 (0.99 to 1.14)   0.094                 
  Asian (vs white)                                  0.95 (0.86 to 1.04)   0.267                 1.03 (0.92 to 1.15)                                 0.636                                                     0.99 (0.89 to 1.11)   0.878                 
  Cardiovascular readmission post index discharge   Black (vs white)      1.22 (1.14 to 1.31)   \<0.001                                             1.23 (1.15 to 1.33)                                       \<0.001               1.20 (1.13 to 1.28)   \<0.001
  Hispanic (vs white)                               1.19 (1.11 to 1.29)   \<0.001               1.23 (1.13 to 1.34)                                 \<0.001                                                   1.15 (1.06 to 1.24)   0.001                 
  Asian (vs white)                                  1.01 (0.91 to 1.12)   0.885                 1.11 (0.98 to 1.27)                                 0.094                                                     1.07 (0.94 to 1.21)   0.286                 
  Mortality/readmission post index discharge        Black (vs white)      1.09 (1.03 to 1.14)   0.001                                               1.12 (1.06 to 1.18)                                       0.001                 1.10 (1.04 to 1.15)   \<0.001
  Hispanic (vs white)                               1.05 (0.98 to 1.12)   0.202                 1.09 (1.02 to 1.17)                                 0.013                                                     1.04 (0.98 to 1.11)   0.192                 
  Asian (vs white)                                  0.92 (0.85 to 1.00)   0.064                 0.99 (0.89 to 1.09)                                 0.820                                                     0.96 (0.87 to 1.06)   0.446                 

Adjustment variables in the multivariable models are patient characteristics including age; sex; past medical history of atrial fibrillation/flutter, anemia, chronic obstructive pulmonary disease, depression, diabetes mellitus, heart failure, hypertension, implantable cardiac defibrillator, ischemic cause, dyslipidemia, pacemaker, peripheral vascular disease, renal insufficiency, cerebrovascular accident/transient ischemic attack, valvular heart disease, smoker; systolic blood pressure, heart rate, and respiratory rate; sodium, serum creatinine, blood urea nitrogen, and hemoglobin; year of index hospitalization; and hospital characteristics including region (Midwest, West, South vs Northeast), number of beds, teaching status, and rural (vs urban). Socioeconomic status characteristics adjustment included mean household income estimate, percentage persons aged ≥25 years with ≥4 years of college, and percentage of persons aged ≥25 years with a high school diploma or greater.

When SES data were added to the multivariable model, we observed that the majority of mortality end points did not change after adjusting for SES variables. Black patients remained at higher risk for rehospitalization compared with white patients, even after accounting for SES. However, the difference in rehospitalization risk, including 30‐day all‐cause and cardiovascular readmission and 1‐year all‐cause readmission, between white and Hispanic patients diminished and became statistically nonsignificant.

Analysis of total readmission days in the first 30 days postdischarge revealed that there was no difference in this end point across racial/ethnic groups after adjusting for patient, hospital, and SES characteristics ([Table 4](#tbl04){ref-type="table"}). For the first 1 year postdischarge, black patients had more rehospitalization stay days within 1 year after patient, hospital, and SES adjustments. Hispanics and Asians also had more rehospitalization stay days after adjusting for patient and hospital characteristics, but the difference became marginally insignificant after further SES adjustment.

###### 

Analysis of Total Number of Hospital Stay Days in First 30 Days and 1 Year After Index Hospital Admission or Index Hospital Discharge by Race/Ethnicity

  Outcome                                                  Comparison                                 Unadjusted            Adjusted for Patient and Hospital Variables   Adjusted for Patient, Hospital, and SES Variables                                               
  -------------------------------------------------------- ------------------------------------------ --------------------- --------------------------------------------- --------------------------------------------------- --------------------- --------------------- -------
  Hospital stay days within 30 days post index discharge   Hispanic (2.1 days) (vs white, 1.8 days)   0.99 (0.88 to 1.11)   0.848                                         0.95 (0.85 to 1.06)                                 0.347                 0.91 (0.82 to 1.01)   0.076
  Black (2.0 days) (vs white)                              0.99 (0.91 to 1.08)                        0.834                 0.95 (0.88 to 1.03)                           0.189                                               0.93 (0.87 to 1.01)   0.075                 
  Asian (2.1 days) (vs white)                              1.16 (0.90 to 1.50)                        0.258                 1.14 (0.87 to 1.49)                           0.347                                               1.11 (0.85 to 1.45)   0.435                 
  Hospital stay days within 1 year post index discharge    Hispanic (13.3 days) (vs white 9.7 days)   1.09 (0.96 to 1.23)   0.183                                         1.25 (1.10 to 1.42)                                 0.001                 1.09 (0.99 to 1.21)   0.086
  Black (13.6 days) (vs white)                             1.12 (1.04 to 1.21)                        0.002                 1.19 (1.09 to 1.30)                           0.001                                               1.13 (1.04 to 1.23)   0.004                 
  Asian (11.0 days) (vs white)                             1.18 (0.90 to 1.54)                        0.226                 1.33 (1.04 to 1.71)                           0.024                                               1.24 (0.99 to 1.53)   0.057                 

Patient characteristics adjustment included age, gender, PMHX (Past medical history), atrial fibrillation/flutter, anemia, chronic obstructive pulmonary disease, depression, diabetes mellitus, heart failure, hypertension, implantable cardiac defibrillator, ischemic cause, dyslipidemia, pacemaker, peripheral vascular disease, renal insufficiency, cerebrovascular accident/transient ischemic attack, valvular heart disease, and smoker, vital signs: systolic blood pressure, heart rate, and respiratory rate, labs: sodium, serum creatinine, blood urea nitrogen, hemoglobin, year of index hospitalization. Hospital characteristics adjustment included region (Midwest, West, South vs Northeast), no. of beds, teaching status, rural (vs urban). Socioeconomic status characteristics adjustment included mean household income estimate, percentage persons aged ≥25 years with ≥4 years of college, and percentage of persons aged ≥25 years with a high school diploma or greater.

Moreover, we examined the interaction by race/ethnicity × region and found that compared with white patients, Hispanics in the West had lower 1‐year mortality risk relative to the other regions ([Table 5](#tbl05){ref-type="table"}).

###### 

Analysis of Interaction Between Race/Ethnicity and Geographic Region

  Outcome                                 Interaction *P* Value              Variable              Hazard Ratio (95% CI)   *P* Value
  --------------------------------------- ---------------------------------- --------------------- ----------------------- -----------
  30‐Day mortality post index admission   0.155                                                                            
  30‐Day mortality post index discharge   0.884                                                                            
  30‐Day all‐cause readmission            0.110                                                                            
  1‐Year mortality post index admission   \<0.001                                                                          
                                          Hispanic (vs white) in Midwest     0.84 (0.66 to 1.08)   0.168                   
                                          Hispanic (vs white) in Northeast   0.93 (0.84 to 1.03)   0.150                   
                                          Hispanic (vs white) in South       1.06 (0.94 to 1.20)   0.319                   
                                          Hispanic (vs white) in West        0.66 (0.57 to 0.76)   \<0.001                 
                                          Black (vs white) in Midwest        0.86 (0.78 to 0.95)   0.003                   
                                          Black (vs white) in Northeast      0.89 (0.80 to 0.99)   0.040                   
                                          Black (vs white) in South          0.89 (0.81 to 0.97)   0.011                   
                                          Black (vs white) in West           0.90 (0.62 to 1.31)   0.581                   
                                          Asian (vs white) in Midwest        0.91 (0.68 to 1.21)   0.522                   
                                          Asian (vs white) in Northeast      0.85 (0.52 to 1.37)   0.498                   
                                          Asian (vs white) in South          1.05 (0.72 to 1.51)   0.812                   
                                          Asian (vs white) in West           0.88 (0.75 to 1.03)   0.120                   
  1‐Year mortality post index discharge   0.003                                                                            
                                          Hispanic (vs white) in Midwest     0.89 (0.66 to 1.18)   0.414                   
                                          Hispanic (vs white) in Northeast   0.96 (0.86 to 1.08)   0.531                   
                                          Hispanic (vs white) in South       1.09 (0.95 to 1.24)   0.219                   
                                          Hispanic (vs white) in West        0.62 (0.52 to 0.76)   \<0.001                 
                                          Black (vs white) in Midwest        0.94 (0.83 to 1.06)   0.309                   
                                          Black (vs white) in Northeast      0.92 (0.82 to 1.02)   0.123                   
                                          Black (vs white) in South          0.94 (0.85 to 1.05)   0.290                   
                                          Black (vs white) in West           0.95 (0.68 to 1.33)   0.786                   
                                          Asian (vs white) in Midwest        1.04 (0.78 to 1.40)   0.788                   
                                          Asian (vs white) in Northeast      0.70 (0.41 to 1.21)   0.200                   
                                          Asian (vs white) in South          1.00 (0.71 to 1.43)   0.985                   
                                          Asian (vs white) in West           0.90 (0.72 to 1.11)   0.327                   
  1‐Year all‐cause readmission            0.111                                                                            

Model adjusted for patient, hospital characteristics, and socioeconomic status variables as displayed in [Table 3](#tbl03){ref-type="table"} footnote.

Discussion
==========

Our results highlight several important racial/ethnic differences in HF outcomes. First, black and Hispanic HF patients had higher 30‐day and 1‐year readmission rates but lower 30‐day and 1‐year mortality, whereas Asian patients had similar 30‐day readmission rates but lower 1‐year mortality relative to white patients. Second, adjustment for patient and hospital characteristics resulted in similar outcomes for black patients but significantly diminished the mortality difference between Hispanic and white patients. Third, after additional adjustment for SES variables, the majority of associations between race/ethnicity group and outcomes persisted, with the exception that there was further reduction in the difference in 30‐day and 1‐year readmission rates between white and Hispanic patients.

A previous analysis of the GWTG‐HF database revealed that black and Hispanic patients hospitalized with HF, despite having more cardiovascular risk factors, had lower in‐hospital mortality rates than white patients.^[@b5]^ By linking with Medicare data for postdischarge outcomes, our results extend these observations by demonstrating that better survival among black patients persists during the 30‐day and 1‐year follow‐up periods, although they were more likely to be readmitted during the same follow‐up intervals. These findings are consistent with data from the OPTIMIZE‐HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) Registry comparing 60‐ to 90‐day outcomes between African Americans and non‐African Americans.^[@b11]^ Other reports using Medicare data described higher 30‐day readmission for HF in black and Hispanic patients, even after controlling for patient and hospital characteristics.^[@b2]--[@b3]^ A multiethnic population study using a California database found that age‐adjusted hospitalization rates were highest in black patients; similar between white and Hispanic patients; and lowest among Asian men. Conversely, black and Hispanic patients were found to be more likely than white and Asian patients to survive for 12 months after the index HF hospitalization.^[@b4]^ Data from other recent studies support the observation of lower adjusted in‐hospital and short‐term mortality in black and Hispanic patients than whites.^[@b6],[@b12]--[@b14]^

Racial/ethnic differences in HF outcomes have been previously explained on the basis of comorbid conditions and quality of care. Consistent with prior registry data, our findings show lower left ventricular ejection fraction, higher brain natriuretic peptide levels, and higher comorbidity burden in black (ie, hypertension and renal insufficiency) and Hispanic patients (ie, diabetes) than in white patients.^[@b5],[@b11],[@b15]^ In reference to quality of HF care, results from both the OPTIMIZE‐HF and GWTG databases demonstrate comparable to better delivery of guideline‐recommended measures of care in blacks and Hispanics relative to white patients.^[@b5],[@b11],[@b15]^ Apart from these differences, another plausible explanation for the seemingly paradoxical observation of higher HF readmission frequency and lower mortality among minorities is poorer socioeconomic resources. A prior analysis of a national sample of Medicare beneficiaries hospitalized with HF between 1998 and 1999 reported that lower‐SES patients had a higher risk of 1‐year readmission and 1‐year mortality compared with higher‐SES patients. Patient SES factors, determined based on the sociodemographic characteristics of the patient\'s ZIP code of residence, were not significantly associated with 30‐day death but were strongly associated with longer‐term outcomes in that population.^[@b6]^ In our study, multivariable adjustment for several SES variables such as household income and markers of higher education reduced intergroup differences in rehospitalization risk (ie, between white and Hispanic patients) but did not significantly impact most of the mortality end points.

How race/ethnicity, as a social determinant, could influence HF outcomes has not been adequately evaluated in prior studies. In this study, black HF patients had lower risk‐adjusted mortality than white patients. Our results suggest that when the analyses are limited to fee‐for‐service Medicare patients (aged \>65 years, have insurance and Social Security), the impact of SES parameters on HF outcomes, mortality in particular, may be blunted. Relative to its effect on HF outcomes, income may be more important among younger patients and less indicative of SES in older, retired individuals.^[@b16]^ Whereas our multivariable model adjusts for patients\' educational level, conventional definitions of education may not completely correlate with health literacy. Race/ethnicity may also be a surrogate for other factors that may account for health disparities. In our and other analyses, collection of SES variables do not incorporate access to care, acculturation, language barrier, health‐related behaviors and cultural beliefs, patient--provider trust, and provider issues of bias and cultural insensitivity.^[@b17]--[@b21]^

Our study has a number of other limitations. As a retrospective observational study, residual measured and unmeasured confounding variables may account for some or all of the findings despite adjustment for multiple variables. Because the study population was composed of patients who were fee‐for‐service Medicare beneficiaries and who were from hospitals participating in the GWTG‐HF program, our results may not be applicable to other HF populations. In this context, our study population is not reflective of the racial/ethnic distribution of the national US population. The method of recording race and ethnicity by patient self‐designation as recorded by administrative staff or admitting providers may be less reliable than direct patient reporting. Moreover, the existing data entry tool for race/ethnicity recording limited our ability to examine differences at the level of white, black, Hispanic, and Asian subpopulations. SES was derived from environment level (ie, residence ZIP code) household income rather than individual attributes. Direct patient‐level measures of SES were not available. Findings for readmission may be influenced by competing risks from mortality.

Conclusions
===========

Among Medicare patients hospitalized with HF, there were important differences in patient characteristics as well as short‐ and long‐term outcomes among 4 racial/ethnic populations. Compared with white patients, black and Hispanic patients had lower 30‐day and 1‐year mortality but higher 30‐day and 1‐year readmission rates. The 30‐day and 1‐year outcomes for Asian and white patients were similar. After controlling for patient clinical characteristics, SES, and hospital‐related variables, black patients had higher 1‐year readmission rates but lower 30‐day and 1‐year mortality; while Hispanic and Asian patients had largely similar risk‐adjusted outcomes, compared with white patients. This study provides evidence of contemporary racial and ethnic‐based differences in HF outcomes and highlights the need for further studies to identify underlying causes for these racial and ethnic differences in care and outcomes of HF patients.
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